Decision Appropriately Balances Access to Treatment with the Need for More Data on the Clinical Value for Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in reaction to the finalized National Coverage Determination decision for monoclonal antibodies for the treatment of […]
Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable Following Another State of the Union Call for Action For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden once again calling for Congress to advance solutions to […]
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Competition, Transparency and Value For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the U.S. Senate confirmation of Dr. Robert M. Califf to serve as commissioner of the U.S. Food […]
Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Drug Prices and Support Market-Based Solutions to Boost Affordability, Competition and Value For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult today. “Voters overwhelmingly view out-of-control prescription […]
Drug Companies Increased Prices on 785 Brand Name Products in First Month of 2022 For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to pharmaceutical industry price hikes on 785 brand name drugs in the first month of 2022 by an average of […]
Next FDA Commissioner Must Promote Competition, Transparency And Value In The Pharmaceutical Marketplace For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) executive session to consider the nomination of Dr. Robert […]
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to Big Pharma increasing prices on 434 brand name drugs in just the first few days of 2022 […]
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s Pricing Practices Are “Unsustainable, Unjustifiable and Unfair” For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to a new report from the U.S. House Committee on Oversight and Reform […]
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices, Reject Pharma-Backed Policies That Would Hike Health Care Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to the U.S. House passage of drug pricing provisions contained in the […]
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by […]